ENTA
#3085
Enanta Pharmaceuticals, Inc. - Common Stock
13.6 0 USD
-0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-1.45%
Changement Mensuel
+9.50%
Evolution sur 6 mois
-3.00%
Changement Annuel
+56.32%
Clôture Précédente
13.8 0
Open
13.6 0
Low
13.6 0
High
13.6 0
Volume
37
Financials
- Market Capitalization 396.11 M
- Employee 120
- Founded 1995
- CEO N/A
- Website www.enanta.com
- Headquarter Massachusetts, United States
- FIGI BBG001V9NSB4
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.12
ratio cours/chiffre d'affaires
0
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3076 |  XFOR X4 Pharmaceuticals, Inc. - Common Stock | 4.04 USD | -4.49% | +0.25% | +2.02% | +36.03% | 400.55 M USD | ||
| 3079 |  LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.86 USD | -2.61% | -0.41% | +11.47% | +1.89% | 398.74 M USD | ||
| 3094 |  CTNM Contineum Therapeutics, Inc. - Common stock | 17.05 USD | -1.16% | +0.29% | +17.75% | +11.66% | 393.84 M USD | ||
| 3108 |  EYPT EyePoint, Inc. - Common Stock | 4.48 USD | -3.24% | -13.35% | -63.19% | -62.67% | 386.23 M USD |